Does BEZLOTOXUMAB Cause Incorrect product administration duration? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Incorrect product administration duration have been filed in association with BEZLOTOXUMAB (ZINPLAVA). This represents 2.3% of all adverse event reports for BEZLOTOXUMAB.
7
Reports of Incorrect product administration duration with BEZLOTOXUMAB
2.3%
of all BEZLOTOXUMAB reports
0
Deaths
7
Hospitalizations
How Dangerous Is Incorrect product administration duration From BEZLOTOXUMAB?
Of the 7 reports, 7 (100.0%) required hospitalization.
Is Incorrect product administration duration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEZLOTOXUMAB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does BEZLOTOXUMAB Cause?
Clostridium difficile infection (119)
Drug ineffective (66)
Treatment failure (43)
Death (19)
Diarrhoea (19)
Pyrexia (18)
Clostridium test positive (16)
Adenovirus infection (13)
Avian influenza (13)
Clostridium difficile colitis (13)
What Other Drugs Cause Incorrect product administration duration?
ETONOGESTREL (3,974)
POLYETHYLENE GLYCOL 3350 (2,129)
NIRMATRELVIR\RITONAVIR (744)
DOCOSANOL (634)
LANSOPRAZOLE (564)
LOPERAMIDE (543)
NAPROXEN (499)
INSULIN LISPRO (479)
DICLOFENAC (362)
OMEPRAZOLE (302)
Which BEZLOTOXUMAB Alternatives Have Lower Incorrect product administration duration Risk?
BEZLOTOXUMAB vs BGB-11417
BEZLOTOXUMAB vs BICALUTAMIDE
BEZLOTOXUMAB vs BICTEGRAVIR
BEZLOTOXUMAB vs BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE
BEZLOTOXUMAB vs BIFIDOBACTERIUM LONGUM